![]() After all, Virbac has had difficulties of its own. Whether the ownership change will alter veterinarians’ perceptions of Sentinel is unclear. The acquisition is anticipated to close during the first quarter of 2015. In April, Eli Lilly announced plans to purchase Novartis Animal Health for $5.4 billion, a deal subject to review by the Federal Trade Commission. (The company introduced Sentinel Spectrum in early 2014.) At the same time, it cut the price of Sentinel Flavor Tabs by nearly half. Some expressed reluctance to do business with Novartis again. But others had switched clients to competing products and were disinclined to switch back. When production resumed in spring 2013, many veterinarians were pleased. Some practitioners were perturbed further to find some online and retail pharmacies appeared not to have the same trouble as clinics in obtaining supplies, leading them to suspect Novartis of duplicitous dealings in the gray market - an accusation Novartis denied. Many private-practice veterinarians expressed frustration with Novartis for poor communications during what turned out to be a 16-month halt in production. Food and Drug Administration inspections that revealed poor quality control and manufacturing mishaps involving human drugs made there. Novartis stopped producing Sentinel and the anti-heartworm drug Interceptor because of a manufacturing plant shutdown in Lincoln, Nebraska, following U.S. Sentinel is one of several veterinary drugs made by Novartis Animal Health in which problems arose in late 2011. ![]() The prospective transfer to Virbac marks the latest turn in an eventful recent business history for Sentinel. Sentinel Spectrum is a soft chew with the same ingredients plus praziquantel to act against tapeworms. Sentinel Flavor Tabs is a chewable tablet that contains milbemycin and lufenuron to act against heartworms, roundworms, hookworms, whipworms and fleas. The antiparasitic drug comes in two formulations. The three-way deal has Virbac acquiring “a combination of titles and rights for the United States on trademarks, marketing authorizations, patents, know-how, customer lists and other assets” on Sentinel, according to an announcement this week. will purchase Sentinel, a monthly parasite-control drug for dogs, as part of the pending sale of Novartis Animal Health to Eli Lilly and Co. Books & VINcyclopedia of Diseases (Formerly Associate). ![]() VINcyclopedia of Diseases (Formerly Associate).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |